Skip to main content
. Author manuscript; available in PMC: 2013 Jun 28.
Published in final edited form as: Pediatrics. 2008 Nov;122(5):911–919. doi: 10.1542/peds.2007-3304

Table 3.

Vaccine Effectiveness (VE) Using Conditional Logistic Regressiona to Estimate Laboratory-Confirmed Influenza-Related Visits by Vaccination Status, Age Group, and Influenza Season

Vaccination Status aOR (95% CI) VE (%) (95% CI) aOR (95% CI) VE (%) (95% CI) aOR (95% CI) VE (%) (95% CI)
2003-2004
Aged 6–59 mo (N = 971) Aged 6–23 mo (N = 537) Aged 24–59 mo (N = 434)
Fully vaccinatedb 0.56 (0.22-1.42) 44 (-42-78) 0.72 (0.23-2.30) 28 (-130-77) 0.34 (0.06-2.06) 66 (-106-94)
Partially vaccinatedb 0.57 (0.32-1.03) 43 (-3-68) 0.58 (0.27-1.22) 42 (-22-73) 0.67 (0.22-2.09) 33 (-109-78)
Age (months)c 1.01d (1.00-1.03) 1.05 (1.00-1.11) 0.98 (0.96-1.01)
Public/no insurancef 1.05 (0.70-1.59) 1.00 (0.55-1.83) 1.02 (0.54-1.91)
Underlying medical condition 0.84 (0.55-1.29) 1.18 (0.62-2.25) 0.62 (0.34-1.13)
2004-2005
Aged 6–59 mo (N =1,493) Aged 6–23 mo (N = 860) Aged 24–59 mo (N = 633)
Fully vaccinatedb 0.43d (0.26-0.72) 57 (28-74) 0.45e (0.23-0.87) 55 (13-77) 0.37e (0.16-0.84) 63 (16-84)
Partially vaccinatedb 0.89 (0.59-1.35) 11 (-35-41) 1.03 (0.62-1.70) -3 (-70-38) 0.62 (0.25-1.53) 38 (-53-75)
Age (months)c 1.00 (0.99-1.02) 1.03 (0.99-1.08) 1.00 (0.98-1.03)
Public/no insurancef 1.43d (0.99-2.06) 1.86e (1.07-3.22) 1.23 (0.73-2.07)
Underlying medical condition 1.03 (0.70-1.51) 0.97 (0.55-1.72) 1.10 (0.63-1.93)
a

Controls were frequency matched to cases on site (Cincinnati, Nashville, or Rochester), visit setting (Inpatient/ED or Clinic), and date of enrollment (controls)/date of influenza symptom onset (cases).

b

Reference = unvaccinated.

c

Indicates unit increase for each additional month of age.

d

P<.01

e

P<.05; otherwise not significant.

f

Reference = private insurance.